Identifi cation of MERS-CoV in dromedary camels
One health-an initiative designed to integrate human and veterinary health-received a boost in The Lancet Infectious Diseases. A multidisciplinary team of scientists from the Netherlands, Qatar, and the UK report the fi rst defi nitive isolation of the Middle East respiratory syndrome coronavirus (MERS-CoV) in a non-human animal species, dromedary camels. 1 Phylogenetic analysis of the 4·2 kb partial viral sequence obtained from one animal show the virus to be almost identical to isolates obtained from two human cases who had had contact with the camels on the aff ected farm. The aff ected smallholding is part of a much larger farm complex located about 30 km northwest of Doha, Qatar, which has been the subject of intensive epidemiological investigation since the diagnosis of the fi rst human case on the farm 2 months ago. 2 Although the virus has only been sequenced from one camel to date, some virological evidence of infection was reported in 11 of 14 camels on the farm, and serological evidence of exposure to a MERS-CoV-like virus was noted in all of them.
The close phylogenetic similarity between virus isolated from people and animals strongly suggests cross-species transmission, but present data do not inform on the direction of that transmission. Notably, the camel and human virus sequences diff er by two substitutions. As the investigators note, this divergence might be the end result of a chain of transmission in animals that introduced mutations. The original source of the detected human and camel infections is unknown, although the sequences closely match an isolate from a human case of MERS-CoV reported in Hafr Al-Batin, Saudi Arabia, in June, 2013.
The detection of MERS-CoV in camels in Qatar is given greater weight by the reported, but as yet unconfi rmed, detection of the virus in a camel in Saudi Arabia 3 and previous fi ndings of antibodies to MERS-CoV, or a very similar virus, in camels in the Canary Islands, Oman, 4 and Egypt. 5 A closely related but not identical virus has also been detected in bats. 6 That MERS-CoV is a zoonosis is not surprising; assessment of the implications will nevertheless be challenging. A particular paradox is the slow rate of growth of the underlying epidemic, whether in camels, human beings, or other reservoir species. Environmental contamination is perhaps one mechanism that might explain the persistence of MERS-CoV in the absence of an explosive epidemic. This hypothesis was given recent support by a bioinformatics analysis suggesting that MERS-CoV virus has the hard outer and inner shell necessary for environmental persistence. 7 An understanding of the role of animals in the transmission of MERS-CoV is urgently needed to inform control eff orts. This virus can spread from person to person, sometimes causing substantial outbreaks, 8, 9 but whether the virus is capable of self-sustained (ie, epidemic) human-to-human transmission is unknown. 10 If self-sustained transmission in people is not yet underway, intensive control and risk-reduction measures targeting aff ected animal species and their handlers might eliminate the virus from the human population. Conversely, if zoonotic exposure causes only a small fraction of human infections, then even intensive veterinary control eff orts would have little eff ect on cases in people. The fi gure shows these scenarios and highlights that low case detection rates do not allow the scenarios to be distinguished from the data now available. About one in fi ve human cases have reported exposure to animals; 11 this might be an underestimate of true zoonotic exposure and growth in case incidence is slow, so there are reasons to be hopeful that animal-targeted controls might be eff ective.
Qatar, supported by WHO and the Food and Agriculture Organization, has done an exemplary integrated outbreak investigation, with rapid collection of specimens from several animal species and the environment on the infected farm. But substantially more genetic and epidemiological data (eg, for timings of exposure events and symptom onsets) from both animal and human cases are needed to unravel the complex transmission dynamics of this virus. Passive and active surveillance in human beings and animals needs to be enhanced across the aff ected region, and livestock trading and movement patterns characterised and monitored. Prompt reporting of outbreaks within the frameworks provided by present human and animal health regulations is essential, but we would add the caveat that such reports need to be as comprehensive as possible to be useful. The handling of the outbreak reported here 1 is a model that we hope is more widely adopted in future. 
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Molecular identifi cation of staphylococcal bacteraemia
An ideal diagnostic technology for bacterial pathogens would identify the infecting organism (or organisms) and establish antibiotic resistance in a timely manner so that appropriate therapy could begin as soon as possible, preferably within 4 h of a specimen arriving in the laboratory. 1,2 Existing phenotypic methods take several days for identifi cation of staphylococcal isolates after clusters of Gram-positive cocci are noted in positive blood cultures. 1,2 A range of molecular devices are now available to rapidly identify and diff erentiate Staphylococcus aureus and coagulasenegative staphylococci from positive blood cultures on the same day (table). 3, 4 Rapid detection and identifi cation of staphylococci could lead to an improvement in use of vancomycin, which is often used empirically to treat patients until susceptibility results are available. 5, [10] [11] [12] Much eff ort is being spent to shorten the time needed for staphylococcus detection and identifi cation. The staphylococcus QuickFISH method (an updated version of PNA FISH) allows for rapid detection of staphylococcus species from positive blood-culture bottles providing a total test-to-result time of less than 30 min. 3 Of 722 positive bloodculture bottles containing clusters of Gram-positive cocci tested, the sensitivity for detection of S aureus
